Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group [see comments]Rüdiger Hehlmann, B Heinze, H. Heimpel et al.|Blood|1994Cited by 458
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study GroupRüdiger Hehlmann, A. Georgii, H. Heimpel et al.|Blood|1993Cited by 207
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trialMaria Pouyiourou, Alwin Krämer, Bianca Kraft et al.|Nature Communications|2023Cited by 36
Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy – A multicenter study on 2419 patients from the prospective skin cancer registry ADORegJulian Kött, N. Devereux, Tim Zell et al.|European Journal of Cancer|2024Cited by 16
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREGCindy Franklin, Selma Ugurel, Peter Mohr et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 14